nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Niacin—atherosclerosis	0.128	0.3	CbGbCtD
Quinidine barbiturate—CYP2D6—Simvastatin—atherosclerosis	0.101	0.237	CbGbCtD
Quinidine barbiturate—CYP2D6—Pravastatin—atherosclerosis	0.0992	0.232	CbGbCtD
Quinidine barbiturate—CYP2D6—Lovastatin—atherosclerosis	0.0992	0.232	CbGbCtD
Quinidine barbiturate—Liver function test abnormal—Niacin—atherosclerosis	0.00217	0.00399	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00216	0.00397	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Niacin—atherosclerosis	0.00215	0.00394	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Pravastatin—atherosclerosis	0.00214	0.00393	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00212	0.00389	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00209	0.00384	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00209	0.00383	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Niacin—atherosclerosis	0.00207	0.00381	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Pravastatin—atherosclerosis	0.00204	0.00375	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00202	0.00371	CcSEcCtD
Quinidine barbiturate—Jaundice—Ezetimibe—atherosclerosis	0.00202	0.0037	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Niacin—atherosclerosis	0.00198	0.00364	CcSEcCtD
Quinidine barbiturate—Mental disorder—Rosuvastatin—atherosclerosis	0.00196	0.0036	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00196	0.00359	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Pravastatin—atherosclerosis	0.00195	0.00358	CcSEcCtD
Quinidine barbiturate—Jaundice—Simvastatin—atherosclerosis	0.00192	0.00353	CcSEcCtD
Quinidine barbiturate—Hepatitis—Lovastatin—atherosclerosis	0.00189	0.00348	CcSEcCtD
Quinidine barbiturate—Hepatitis—Ezetimibe—atherosclerosis	0.00186	0.00341	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00183	0.00335	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Lovastatin—atherosclerosis	0.00179	0.00329	CcSEcCtD
Quinidine barbiturate—Angioedema—Rosuvastatin—atherosclerosis	0.00178	0.00326	CcSEcCtD
Quinidine barbiturate—Hepatitis—Simvastatin—atherosclerosis	0.00177	0.00325	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00177	0.00325	CcSEcCtD
Quinidine barbiturate—Jaundice—Niacin—atherosclerosis	0.00177	0.00324	CcSEcCtD
Quinidine barbiturate—Flushing—Lovastatin—atherosclerosis	0.00176	0.00323	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Ezetimibe—atherosclerosis	0.00176	0.00323	CcSEcCtD
Quinidine barbiturate—Jaundice—Pravastatin—atherosclerosis	0.00174	0.00319	CcSEcCtD
Quinidine barbiturate—Sweating—Niacin—atherosclerosis	0.00174	0.00319	CcSEcCtD
Quinidine barbiturate—Flushing—Ezetimibe—atherosclerosis	0.00172	0.00317	CcSEcCtD
Quinidine barbiturate—Chills—Lovastatin—atherosclerosis	0.0017	0.00312	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Ezetimibe—atherosclerosis	0.00168	0.00308	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Simvastatin—atherosclerosis	0.00168	0.00308	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00167	0.00307	CcSEcCtD
Quinidine barbiturate—Arthralgia—Rosuvastatin—atherosclerosis	0.00166	0.00304	CcSEcCtD
Quinidine barbiturate—Myalgia—Rosuvastatin—atherosclerosis	0.00166	0.00304	CcSEcCtD
Quinidine barbiturate—Flushing—Simvastatin—atherosclerosis	0.00164	0.00302	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Niacin—atherosclerosis	0.00164	0.003	CcSEcCtD
Quinidine barbiturate—Mental disorder—Ezetimibe—atherosclerosis	0.00163	0.00299	CcSEcCtD
Quinidine barbiturate—Hepatitis—Niacin—atherosclerosis	0.00163	0.00299	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Niacin—atherosclerosis	0.00163	0.00299	CcSEcCtD
Quinidine barbiturate—Malnutrition—Ezetimibe—atherosclerosis	0.00162	0.00297	CcSEcCtD
Quinidine barbiturate—Erythema—Ezetimibe—atherosclerosis	0.00162	0.00297	CcSEcCtD
Quinidine barbiturate—Hepatitis—Pravastatin—atherosclerosis	0.0016	0.00294	CcSEcCtD
Quinidine barbiturate—Confusional state—Rosuvastatin—atherosclerosis	0.0016	0.00294	CcSEcCtD
Quinidine barbiturate—Chills—Simvastatin—atherosclerosis	0.00159	0.00292	CcSEcCtD
Quinidine barbiturate—Visual impairment—Niacin—atherosclerosis	0.00157	0.00288	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00156	0.00286	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00155	0.00285	CcSEcCtD
Quinidine barbiturate—Vision blurred—Lovastatin—atherosclerosis	0.00155	0.00285	CcSEcCtD
Quinidine barbiturate—Mental disorder—Simvastatin—atherosclerosis	0.00155	0.00285	CcSEcCtD
Quinidine barbiturate—Tremor—Lovastatin—atherosclerosis	0.00155	0.00284	CcSEcCtD
Quinidine barbiturate—Visual impairment—Pravastatin—atherosclerosis	0.00154	0.00283	CcSEcCtD
Quinidine barbiturate—Erythema—Simvastatin—atherosclerosis	0.00154	0.00283	CcSEcCtD
Quinidine barbiturate—Eye disorder—Niacin—atherosclerosis	0.00152	0.00279	CcSEcCtD
Quinidine barbiturate—Tinnitus—Niacin—atherosclerosis	0.00152	0.00279	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Pravastatin—atherosclerosis	0.00151	0.00278	CcSEcCtD
Quinidine barbiturate—Flushing—Niacin—atherosclerosis	0.00151	0.00277	CcSEcCtD
Quinidine barbiturate—Angioedema—Lovastatin—atherosclerosis	0.00151	0.00277	CcSEcCtD
Quinidine barbiturate—Tinnitus—Pravastatin—atherosclerosis	0.00149	0.00274	CcSEcCtD
Quinidine barbiturate—Flushing—Pravastatin—atherosclerosis	0.00149	0.00273	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Pravastatin—atherosclerosis	0.00149	0.00273	CcSEcCtD
Quinidine barbiturate—Vertigo—Lovastatin—atherosclerosis	0.00148	0.00272	CcSEcCtD
Quinidine barbiturate—Angioedema—Ezetimibe—atherosclerosis	0.00148	0.00271	CcSEcCtD
Quinidine barbiturate—Leukopenia—Lovastatin—atherosclerosis	0.00148	0.00271	CcSEcCtD
Quinidine barbiturate—Chills—Niacin—atherosclerosis	0.00146	0.00268	CcSEcCtD
Quinidine barbiturate—Vision blurred—Simvastatin—atherosclerosis	0.00145	0.00267	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00145	0.00266	CcSEcCtD
Quinidine barbiturate—Tremor—Simvastatin—atherosclerosis	0.00145	0.00265	CcSEcCtD
Quinidine barbiturate—Chills—Pravastatin—atherosclerosis	0.00144	0.00264	CcSEcCtD
Quinidine barbiturate—Palpitations—Ezetimibe—atherosclerosis	0.00143	0.00262	CcSEcCtD
Quinidine barbiturate—Erythema—Niacin—atherosclerosis	0.00142	0.0026	CcSEcCtD
Quinidine barbiturate—Malnutrition—Niacin—atherosclerosis	0.00142	0.0026	CcSEcCtD
Quinidine barbiturate—Angioedema—Simvastatin—atherosclerosis	0.00141	0.00259	CcSEcCtD
Quinidine barbiturate—Chest pain—Lovastatin—atherosclerosis	0.0014	0.00258	CcSEcCtD
Quinidine barbiturate—Myalgia—Lovastatin—atherosclerosis	0.0014	0.00258	CcSEcCtD
Quinidine barbiturate—Arthralgia—Lovastatin—atherosclerosis	0.0014	0.00258	CcSEcCtD
Quinidine barbiturate—Anxiety—Lovastatin—atherosclerosis	0.0014	0.00257	CcSEcCtD
Quinidine barbiturate—Tension—Niacin—atherosclerosis	0.00139	0.00255	CcSEcCtD
Quinidine barbiturate—Vertigo—Simvastatin—atherosclerosis	0.00139	0.00254	CcSEcCtD
Quinidine barbiturate—Leukopenia—Simvastatin—atherosclerosis	0.00138	0.00253	CcSEcCtD
Quinidine barbiturate—Arthralgia—Ezetimibe—atherosclerosis	0.00138	0.00253	CcSEcCtD
Quinidine barbiturate—Chest pain—Ezetimibe—atherosclerosis	0.00138	0.00253	CcSEcCtD
Quinidine barbiturate—Myalgia—Ezetimibe—atherosclerosis	0.00138	0.00253	CcSEcCtD
Quinidine barbiturate—Nervousness—Niacin—atherosclerosis	0.00138	0.00253	CcSEcCtD
Quinidine barbiturate—Tension—Pravastatin—atherosclerosis	0.00137	0.00251	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00137	0.00251	CcSEcCtD
Quinidine barbiturate—Constipation—Rosuvastatin—atherosclerosis	0.00136	0.00249	CcSEcCtD
Quinidine barbiturate—Pain—Rosuvastatin—atherosclerosis	0.00136	0.00249	CcSEcCtD
Quinidine barbiturate—Confusional state—Lovastatin—atherosclerosis	0.00136	0.00249	CcSEcCtD
Quinidine barbiturate—Nervousness—Pravastatin—atherosclerosis	0.00135	0.00249	CcSEcCtD
Quinidine barbiturate—Vision blurred—Niacin—atherosclerosis	0.00133	0.00245	CcSEcCtD
Quinidine barbiturate—Confusional state—Ezetimibe—atherosclerosis	0.00133	0.00244	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00132	0.00242	CcSEcCtD
Quinidine barbiturate—Vision blurred—Pravastatin—atherosclerosis	0.00131	0.00241	CcSEcCtD
Quinidine barbiturate—Arthralgia—Simvastatin—atherosclerosis	0.00131	0.00241	CcSEcCtD
Quinidine barbiturate—Chest pain—Simvastatin—atherosclerosis	0.00131	0.00241	CcSEcCtD
Quinidine barbiturate—Myalgia—Simvastatin—atherosclerosis	0.00131	0.00241	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00131	0.0024	CcSEcCtD
Quinidine barbiturate—Anxiety—Simvastatin—atherosclerosis	0.00131	0.0024	CcSEcCtD
Quinidine barbiturate—Tremor—Pravastatin—atherosclerosis	0.00131	0.0024	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.0013	0.00238	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00129	0.00238	CcSEcCtD
Quinidine barbiturate—Angioedema—Niacin—atherosclerosis	0.00129	0.00238	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00129	0.00237	CcSEcCtD
Quinidine barbiturate—Anorexia—Lovastatin—atherosclerosis	0.00128	0.00236	CcSEcCtD
Quinidine barbiturate—Skin disorder—Ezetimibe—atherosclerosis	0.00128	0.00235	CcSEcCtD
Quinidine barbiturate—Angioedema—Pravastatin—atherosclerosis	0.00127	0.00234	CcSEcCtD
Quinidine barbiturate—Vertigo—Niacin—atherosclerosis	0.00127	0.00234	CcSEcCtD
Quinidine barbiturate—Syncope—Niacin—atherosclerosis	0.00127	0.00233	CcSEcCtD
Quinidine barbiturate—Confusional state—Simvastatin—atherosclerosis	0.00127	0.00233	CcSEcCtD
Quinidine barbiturate—Leukopenia—Niacin—atherosclerosis	0.00127	0.00233	CcSEcCtD
Quinidine barbiturate—Urticaria—Rosuvastatin—atherosclerosis	0.00126	0.00232	CcSEcCtD
Quinidine barbiturate—Oedema—Simvastatin—atherosclerosis	0.00126	0.00231	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00126	0.0023	CcSEcCtD
Quinidine barbiturate—Vertigo—Pravastatin—atherosclerosis	0.00125	0.0023	CcSEcCtD
Quinidine barbiturate—Palpitations—Niacin—atherosclerosis	0.00125	0.0023	CcSEcCtD
Quinidine barbiturate—Leukopenia—Pravastatin—atherosclerosis	0.00125	0.00229	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Niacin—atherosclerosis	0.00124	0.00229	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00123	0.00226	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00123	0.00225	CcSEcCtD
Quinidine barbiturate—Myalgia—Niacin—atherosclerosis	0.00121	0.00221	CcSEcCtD
Quinidine barbiturate—Arthralgia—Niacin—atherosclerosis	0.00121	0.00221	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0012	0.00221	CcSEcCtD
Quinidine barbiturate—Anorexia—Simvastatin—atherosclerosis	0.0012	0.0022	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Lovastatin—atherosclerosis	0.0012	0.0022	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0012	0.0022	CcSEcCtD
Quinidine barbiturate—Arthralgia—Pravastatin—atherosclerosis	0.00119	0.00218	CcSEcCtD
Quinidine barbiturate—Myalgia—Pravastatin—atherosclerosis	0.00119	0.00218	CcSEcCtD
Quinidine barbiturate—Chest pain—Pravastatin—atherosclerosis	0.00119	0.00218	CcSEcCtD
Quinidine barbiturate—Anxiety—Pravastatin—atherosclerosis	0.00118	0.00217	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Ezetimibe—atherosclerosis	0.00118	0.00216	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00117	0.00215	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Lovastatin—atherosclerosis	0.00117	0.00215	CcSEcCtD
Quinidine barbiturate—Oedema—Niacin—atherosclerosis	0.00116	0.00212	CcSEcCtD
Quinidine barbiturate—Constipation—Lovastatin—atherosclerosis	0.00115	0.00211	CcSEcCtD
Quinidine barbiturate—Pain—Lovastatin—atherosclerosis	0.00115	0.00211	CcSEcCtD
Quinidine barbiturate—Confusional state—Pravastatin—atherosclerosis	0.00115	0.00211	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Ezetimibe—atherosclerosis	0.00115	0.00211	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00115	0.00211	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00114	0.00209	CcSEcCtD
Quinidine barbiturate—Asthenia—Rosuvastatin—atherosclerosis	0.00114	0.00209	CcSEcCtD
Quinidine barbiturate—Oedema—Pravastatin—atherosclerosis	0.00114	0.00209	CcSEcCtD
Quinidine barbiturate—Shock—Niacin—atherosclerosis	0.00114	0.00209	CcSEcCtD
Quinidine barbiturate—Pain—Ezetimibe—atherosclerosis	0.00113	0.00207	CcSEcCtD
Quinidine barbiturate—Constipation—Ezetimibe—atherosclerosis	0.00113	0.00207	CcSEcCtD
Quinidine barbiturate—Tachycardia—Niacin—atherosclerosis	0.00113	0.00207	CcSEcCtD
Quinidine barbiturate—Pruritus—Rosuvastatin—atherosclerosis	0.00112	0.00206	CcSEcCtD
Quinidine barbiturate—Skin disorder—Niacin—atherosclerosis	0.00112	0.00206	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Simvastatin—atherosclerosis	0.00112	0.00206	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Niacin—atherosclerosis	0.00112	0.00205	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Pravastatin—atherosclerosis	0.00111	0.00205	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Lovastatin—atherosclerosis	0.00111	0.00204	CcSEcCtD
Quinidine barbiturate—Anorexia—Niacin—atherosclerosis	0.0011	0.00202	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0011	0.00202	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Pravastatin—atherosclerosis	0.0011	0.00202	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Simvastatin—atherosclerosis	0.00109	0.00201	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00109	0.002	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00109	0.002	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00109	0.00199	CcSEcCtD
Quinidine barbiturate—Anorexia—Pravastatin—atherosclerosis	0.00108	0.00199	CcSEcCtD
Quinidine barbiturate—Hypotension—Niacin—atherosclerosis	0.00108	0.00198	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00108	0.00198	CcSEcCtD
Quinidine barbiturate—Pain—Simvastatin—atherosclerosis	0.00108	0.00198	CcSEcCtD
Quinidine barbiturate—Constipation—Simvastatin—atherosclerosis	0.00108	0.00198	CcSEcCtD
Quinidine barbiturate—Urticaria—Lovastatin—atherosclerosis	0.00107	0.00196	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Lovastatin—atherosclerosis	0.00106	0.00195	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Lovastatin—atherosclerosis	0.00106	0.00195	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00105	0.00193	CcSEcCtD
Quinidine barbiturate—Dizziness—Rosuvastatin—atherosclerosis	0.00105	0.00193	CcSEcCtD
Quinidine barbiturate—Urticaria—Ezetimibe—atherosclerosis	0.00105	0.00193	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Ezetimibe—atherosclerosis	0.00104	0.00192	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Ezetimibe—atherosclerosis	0.00104	0.00192	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Simvastatin—atherosclerosis	0.00104	0.0019	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00104	0.0019	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Niacin—atherosclerosis	0.00103	0.00189	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00103	0.00189	CcSEcCtD
Quinidine barbiturate—Somnolence—Niacin—atherosclerosis	0.00103	0.00189	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Pravastatin—atherosclerosis	0.00101	0.00186	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Niacin—atherosclerosis	0.001	0.00184	CcSEcCtD
Quinidine barbiturate—Rash—Rosuvastatin—atherosclerosis	0.001	0.00184	CcSEcCtD
Quinidine barbiturate—Dermatitis—Rosuvastatin—atherosclerosis	0.001	0.00184	CcSEcCtD
Quinidine barbiturate—Urticaria—Simvastatin—atherosclerosis	0.001	0.00184	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000998	0.00183	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Simvastatin—atherosclerosis	0.000995	0.00183	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Simvastatin—atherosclerosis	0.000995	0.00183	CcSEcCtD
Quinidine barbiturate—Headache—Rosuvastatin—atherosclerosis	0.000995	0.00183	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Lovastatin—atherosclerosis	0.000992	0.00182	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Pravastatin—atherosclerosis	0.000989	0.00182	CcSEcCtD
Quinidine barbiturate—Pain—Niacin—atherosclerosis	0.000988	0.00181	CcSEcCtD
Quinidine barbiturate—Pain—Pravastatin—atherosclerosis	0.000973	0.00179	CcSEcCtD
Quinidine barbiturate—Constipation—Pravastatin—atherosclerosis	0.000973	0.00179	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000973	0.00179	CcSEcCtD
Quinidine barbiturate—Asthenia—Lovastatin—atherosclerosis	0.000966	0.00177	CcSEcCtD
Quinidine barbiturate—Pruritus—Lovastatin—atherosclerosis	0.000952	0.00175	CcSEcCtD
Quinidine barbiturate—Asthenia—Ezetimibe—atherosclerosis	0.000947	0.00174	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Niacin—atherosclerosis	0.000945	0.00174	CcSEcCtD
Quinidine barbiturate—Nausea—Rosuvastatin—atherosclerosis	0.000943	0.00173	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Pravastatin—atherosclerosis	0.000938	0.00172	CcSEcCtD
Quinidine barbiturate—Pruritus—Ezetimibe—atherosclerosis	0.000934	0.00171	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000931	0.00171	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Simvastatin—atherosclerosis	0.000927	0.0017	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Lovastatin—atherosclerosis	0.000921	0.00169	CcSEcCtD
Quinidine barbiturate—Urticaria—Niacin—atherosclerosis	0.000918	0.00169	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Niacin—atherosclerosis	0.000914	0.00168	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Niacin—atherosclerosis	0.000914	0.00168	CcSEcCtD
Quinidine barbiturate—Urticaria—Pravastatin—atherosclerosis	0.000904	0.00166	CcSEcCtD
Quinidine barbiturate—Asthenia—Simvastatin—atherosclerosis	0.000903	0.00166	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Ezetimibe—atherosclerosis	0.000903	0.00166	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Pravastatin—atherosclerosis	0.0009	0.00165	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Pravastatin—atherosclerosis	0.0009	0.00165	CcSEcCtD
Quinidine barbiturate—Pruritus—Simvastatin—atherosclerosis	0.000891	0.00164	CcSEcCtD
Quinidine barbiturate—Dizziness—Lovastatin—atherosclerosis	0.00089	0.00163	CcSEcCtD
Quinidine barbiturate—Dizziness—Ezetimibe—atherosclerosis	0.000873	0.0016	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Simvastatin—atherosclerosis	0.000861	0.00158	CcSEcCtD
Quinidine barbiturate—Vomiting—Lovastatin—atherosclerosis	0.000856	0.00157	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Niacin—atherosclerosis	0.000852	0.00156	CcSEcCtD
Quinidine barbiturate—Rash—Lovastatin—atherosclerosis	0.000849	0.00156	CcSEcCtD
Quinidine barbiturate—Dermatitis—Lovastatin—atherosclerosis	0.000848	0.00156	CcSEcCtD
Quinidine barbiturate—Headache—Lovastatin—atherosclerosis	0.000843	0.00155	CcSEcCtD
Quinidine barbiturate—Vomiting—Ezetimibe—atherosclerosis	0.000839	0.00154	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Pravastatin—atherosclerosis	0.000839	0.00154	CcSEcCtD
Quinidine barbiturate—Dizziness—Simvastatin—atherosclerosis	0.000832	0.00153	CcSEcCtD
Quinidine barbiturate—Rash—Ezetimibe—atherosclerosis	0.000832	0.00153	CcSEcCtD
Quinidine barbiturate—Dermatitis—Ezetimibe—atherosclerosis	0.000832	0.00153	CcSEcCtD
Quinidine barbiturate—Asthenia—Niacin—atherosclerosis	0.000829	0.00152	CcSEcCtD
Quinidine barbiturate—Headache—Ezetimibe—atherosclerosis	0.000827	0.00152	CcSEcCtD
Quinidine barbiturate—Pruritus—Niacin—atherosclerosis	0.000818	0.0015	CcSEcCtD
Quinidine barbiturate—Asthenia—Pravastatin—atherosclerosis	0.000817	0.0015	CcSEcCtD
Quinidine barbiturate—Pruritus—Pravastatin—atherosclerosis	0.000805	0.00148	CcSEcCtD
Quinidine barbiturate—Vomiting—Simvastatin—atherosclerosis	0.0008	0.00147	CcSEcCtD
Quinidine barbiturate—Nausea—Lovastatin—atherosclerosis	0.000799	0.00147	CcSEcCtD
Quinidine barbiturate—Rash—Simvastatin—atherosclerosis	0.000794	0.00146	CcSEcCtD
Quinidine barbiturate—Dermatitis—Simvastatin—atherosclerosis	0.000793	0.00146	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Niacin—atherosclerosis	0.000791	0.00145	CcSEcCtD
Quinidine barbiturate—Headache—Simvastatin—atherosclerosis	0.000789	0.00145	CcSEcCtD
Quinidine barbiturate—Nausea—Ezetimibe—atherosclerosis	0.000784	0.00144	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Pravastatin—atherosclerosis	0.000779	0.00143	CcSEcCtD
Quinidine barbiturate—Dizziness—Niacin—atherosclerosis	0.000764	0.0014	CcSEcCtD
Quinidine barbiturate—Dizziness—Pravastatin—atherosclerosis	0.000753	0.00138	CcSEcCtD
Quinidine barbiturate—Nausea—Simvastatin—atherosclerosis	0.000748	0.00137	CcSEcCtD
Quinidine barbiturate—Vomiting—Niacin—atherosclerosis	0.000735	0.00135	CcSEcCtD
Quinidine barbiturate—Rash—Niacin—atherosclerosis	0.000729	0.00134	CcSEcCtD
Quinidine barbiturate—Dermatitis—Niacin—atherosclerosis	0.000728	0.00134	CcSEcCtD
Quinidine barbiturate—Headache—Niacin—atherosclerosis	0.000724	0.00133	CcSEcCtD
Quinidine barbiturate—Vomiting—Pravastatin—atherosclerosis	0.000724	0.00133	CcSEcCtD
Quinidine barbiturate—Rash—Pravastatin—atherosclerosis	0.000718	0.00132	CcSEcCtD
Quinidine barbiturate—Dermatitis—Pravastatin—atherosclerosis	0.000717	0.00132	CcSEcCtD
Quinidine barbiturate—Headache—Pravastatin—atherosclerosis	0.000713	0.00131	CcSEcCtD
Quinidine barbiturate—Nausea—Niacin—atherosclerosis	0.000687	0.00126	CcSEcCtD
Quinidine barbiturate—Nausea—Pravastatin—atherosclerosis	0.000676	0.00124	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK3—atherosclerosis	6.83e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	6.8e-05	0.00249	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	6.73e-05	0.00247	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	6.72e-05	0.00247	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	6.72e-05	0.00247	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	6.59e-05	0.00242	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.48e-05	0.00238	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—PRKCG—atherosclerosis	6.43e-05	0.00236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PDGFB—atherosclerosis	6.39e-05	0.00235	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	6.37e-05	0.00234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—UTS2—atherosclerosis	6.33e-05	0.00232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—KNG1—atherosclerosis	6.2e-05	0.00227	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	6.17e-05	0.00226	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CX3CR1—atherosclerosis	6.07e-05	0.00223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CASR—atherosclerosis	6.07e-05	0.00223	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	5.98e-05	0.00219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CX3CL1—atherosclerosis	5.95e-05	0.00218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—F2—atherosclerosis	5.77e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	5.76e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	5.76e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	5.72e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CNR2—atherosclerosis	5.64e-05	0.00207	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.62e-05	0.00206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	5.61e-05	0.00206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HRH1—atherosclerosis	5.55e-05	0.00204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—atherosclerosis	5.52e-05	0.00203	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—PRKCG—atherosclerosis	5.49e-05	0.00201	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—LPL—atherosclerosis	5.42e-05	0.00199	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—atherosclerosis	5.29e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCL5—atherosclerosis	5.18e-05	0.0019	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CD36—atherosclerosis	5.15e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	5.12e-05	0.00188	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP2—atherosclerosis	5.09e-05	0.00187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRH1—atherosclerosis	5.04e-05	0.00185	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	5e-05	0.00184	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.96e-05	0.00182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	4.93e-05	0.00181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	4.9e-05	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL3—atherosclerosis	4.85e-05	0.00178	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	4.8e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CETP—atherosclerosis	4.8e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARA—atherosclerosis	4.79e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—atherosclerosis	4.6e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—LEP—atherosclerosis	4.54e-05	0.00167	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	4.48e-05	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR2—atherosclerosis	4.39e-05	0.00161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—EDNRA—atherosclerosis	4.39e-05	0.00161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—AGT—atherosclerosis	4.33e-05	0.00159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GHRL—atherosclerosis	4.27e-05	0.00157	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.27e-05	0.00157	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.23e-05	0.00155	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PLG—atherosclerosis	4.21e-05	0.00155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	4.15e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.14e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	4.12e-05	0.00151	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	4.06e-05	0.00149	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	4e-05	0.00147	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARG—atherosclerosis	3.96e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	3.95e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	3.92e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.89e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—INS—atherosclerosis	3.88e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—atherosclerosis	3.83e-05	0.00141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	3.76e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—KNG1—atherosclerosis	3.75e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGTR1—atherosclerosis	3.73e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.73e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL4—atherosclerosis	3.64e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—atherosclerosis	3.63e-05	0.00133	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.59e-05	0.00132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—UTS2—atherosclerosis	3.58e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	3.51e-05	0.00129	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	3.48e-05	0.00128	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	3.45e-05	0.00126	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—atherosclerosis	3.44e-05	0.00126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CASR—atherosclerosis	3.43e-05	0.00126	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.32e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK3—atherosclerosis	3.25e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—UTS2—atherosclerosis	3.25e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CNR2—atherosclerosis	3.19e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	3.18e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	3.18e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.18e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—EDN1—atherosclerosis	3.16e-05	0.00116	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.14e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL5—atherosclerosis	3.14e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	3.12e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CX3CR1—atherosclerosis	3.11e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CASR—atherosclerosis	3.11e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CX3CL1—atherosclerosis	3.05e-05	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRH1—atherosclerosis	2.98e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.95e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CNR2—atherosclerosis	2.89e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	2.84e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	2.84e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—atherosclerosis	2.82e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.81e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—atherosclerosis	2.73e-05	0.001	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—atherosclerosis	2.73e-05	0.001	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NFKB1—atherosclerosis	2.7e-05	0.000992	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.68e-05	0.000984	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLTP—atherosclerosis	2.67e-05	0.000979	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGT—atherosclerosis	2.62e-05	0.000963	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.51e-05	0.000923	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL3—atherosclerosis	2.49e-05	0.000914	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR2—atherosclerosis	2.48e-05	0.00091	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDNRA—atherosclerosis	2.48e-05	0.00091	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—atherosclerosis	2.45e-05	0.0009	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—atherosclerosis	2.43e-05	0.000891	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—F2—atherosclerosis	2.42e-05	0.00089	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GHRL—atherosclerosis	2.42e-05	0.000887	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—atherosclerosis	2.38e-05	0.000873	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA4—atherosclerosis	2.34e-05	0.000857	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.34e-05	0.000857	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK3—atherosclerosis	2.32e-05	0.000852	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LTA4H—atherosclerosis	2.31e-05	0.000849	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG8—atherosclerosis	2.31e-05	0.000849	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—atherosclerosis	2.25e-05	0.000826	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR2—atherosclerosis	2.25e-05	0.000826	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDNRA—atherosclerosis	2.25e-05	0.000826	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	2.24e-05	0.000824	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.2e-05	0.000808	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GHRL—atherosclerosis	2.19e-05	0.000805	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL2—atherosclerosis	2.16e-05	0.000793	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL4—atherosclerosis	2.15e-05	0.00079	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	2.12e-05	0.000778	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	2.11e-05	0.000774	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—atherosclerosis	2.1e-05	0.000772	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA2—atherosclerosis	2.01e-05	0.000738	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.99e-05	0.000731	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	1.93e-05	0.000707	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—UTS2—atherosclerosis	1.92e-05	0.000704	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	1.91e-05	0.000702	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	1.84e-05	0.000675	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASR—atherosclerosis	1.84e-05	0.000675	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.83e-05	0.000671	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	1.8e-05	0.000662	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	1.79e-05	0.000656	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	1.77e-05	0.000651	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LCAT—atherosclerosis	1.72e-05	0.000631	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—FABP4—atherosclerosis	1.72e-05	0.000631	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR2—atherosclerosis	1.71e-05	0.000628	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	1.71e-05	0.000627	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	1.71e-05	0.000626	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—atherosclerosis	1.7e-05	0.000623	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA4—atherosclerosis	1.69e-05	0.000619	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	1.69e-05	0.000619	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.66e-05	0.000608	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	1.62e-05	0.000596	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	1.61e-05	0.000591	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.57e-05	0.000574	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.53e-05	0.000562	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	1.53e-05	0.000562	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VWF—atherosclerosis	1.52e-05	0.000559	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOC3—atherosclerosis	1.51e-05	0.000556	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LDLR—atherosclerosis	1.51e-05	0.000553	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	1.48e-05	0.000544	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL3—atherosclerosis	1.47e-05	0.00054	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.45e-05	0.000533	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.45e-05	0.000533	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.45e-05	0.000533	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA2—atherosclerosis	1.45e-05	0.000533	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.43e-05	0.000526	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NCF1—atherosclerosis	1.41e-05	0.000517	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPA—atherosclerosis	1.39e-05	0.000508	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—F2—atherosclerosis	1.37e-05	0.000503	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGT—atherosclerosis	1.35e-05	0.000494	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BGN—atherosclerosis	1.34e-05	0.000492	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	1.33e-05	0.000488	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR2—atherosclerosis	1.33e-05	0.000488	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA5—atherosclerosis	1.33e-05	0.000487	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CYBA—atherosclerosis	1.32e-05	0.000486	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.31e-05	0.000481	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GHRL—atherosclerosis	1.3e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PARP1—atherosclerosis	1.3e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLAT—atherosclerosis	1.3e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.28e-05	0.000469	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—F2—atherosclerosis	1.24e-05	0.000457	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.23e-05	0.000453	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	1.19e-05	0.000437	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KNG1—atherosclerosis	1.14e-05	0.000417	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	1.13e-05	0.000415	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.11e-05	0.000407	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.11e-05	0.000406	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.1e-05	0.000404	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000404	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000401	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LDLR—atherosclerosis	1.09e-05	0.000399	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CETP—atherosclerosis	1.06e-05	0.00039	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.04e-05	0.000383	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.02e-05	0.000373	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP3—atherosclerosis	1.01e-05	0.00037	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—atherosclerosis	1e-05	0.000368	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOB—atherosclerosis	9.74e-06	0.000357	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	9.66e-06	0.000354	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.6e-06	0.000352	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDN1—atherosclerosis	9.58e-06	0.000352	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL5—atherosclerosis	9.51e-06	0.000349	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPL—atherosclerosis	9.3e-06	0.000341	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	9.04e-06	0.000332	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPP1—atherosclerosis	8.81e-06	0.000323	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	8.77e-06	0.000322	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.56e-06	0.000314	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	8.15e-06	0.000299	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGT—atherosclerosis	7.96e-06	0.000292	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEP—atherosclerosis	7.8e-06	0.000286	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—atherosclerosis	7.8e-06	0.000286	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CAV1—atherosclerosis	7.72e-06	0.000283	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA1—atherosclerosis	7.71e-06	0.000283	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—atherosclerosis	7.44e-06	0.000273	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2—atherosclerosis	7.35e-06	0.00027	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.34e-06	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	7.04e-06	0.000258	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOB—atherosclerosis	7.03e-06	0.000258	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.84e-06	0.000251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	6.74e-06	0.000247	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPL—atherosclerosis	6.72e-06	0.000246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—atherosclerosis	6.66e-06	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL2—atherosclerosis	6.55e-06	0.00024	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPX1—atherosclerosis	6.55e-06	0.00024	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—atherosclerosis	6.44e-06	0.000236	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD36—atherosclerosis	6.38e-06	0.000234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	6.12e-06	0.000225	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.05e-06	0.000222	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARA—atherosclerosis	5.93e-06	0.000218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—atherosclerosis	5.84e-06	0.000214	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AGT—atherosclerosis	5.74e-06	0.000211	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—atherosclerosis	5.63e-06	0.000207	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAV1—atherosclerosis	5.58e-06	0.000205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA1—atherosclerosis	5.56e-06	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	5.18e-06	0.00019	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.08e-06	0.000186	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	5e-06	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—atherosclerosis	4.93e-06	0.000181	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—atherosclerosis	4.9e-06	0.00018	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—atherosclerosis	4.81e-06	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—atherosclerosis	4.69e-06	0.000172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	4.64e-06	0.00017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	4.56e-06	0.000167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	4.54e-06	0.000167	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—atherosclerosis	4.41e-06	0.000162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—atherosclerosis	4.22e-06	0.000155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	4.21e-06	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—atherosclerosis	4.17e-06	0.000153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.98e-06	0.000146	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.86e-06	0.000142	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.86e-06	0.000142	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.91e-06	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.68e-06	9.85e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—atherosclerosis	1.94e-06	7.12e-05	CbGpPWpGaD
